Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 115 articles:
HTML format
Text format



Single Articles


    September 2019
  1. PRINTZ C
    First person profile: Leslie Bernstein, PhD: An epidemiologist known for her groundbreaking discoveries about breast cancer, Dr. Bernstein continues to push the field forward.
    Cancer. 2019;125:2907-2909.
    PubMed     Text format    


    August 2019
  2. WANG T, McCullough LE, White AJ, Bradshaw PT, et al
    Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Cancer. 2019 Aug 12. doi: 10.1002/cncr.32364.
    PubMed     Text format     Abstract available


  3. MALECKI KMC
    Epigenetics and differential effects of aspirin on breast cancer survival: Opportunities for understanding human susceptibility and risk.
    Cancer. 2019 Aug 12. doi: 10.1002/cncr.32365.
    PubMed     Text format    


  4. REEDER-HAYES KE, Mayer SE, Olshan AF, Wheeler SB, et al
    Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study.
    Cancer. 2019 Aug 9. doi: 10.1002/cncr.32378.
    PubMed     Text format     Abstract available


  5. MILES RC, Lehman CD, Mercaldo SF, Tamimi RM, et al
    Obesity and breast cancer screening: Cross-sectional survey results from the behavioral risk factor surveillance system.
    Cancer. 2019 Aug 8. doi: 10.1002/cncr.32430.
    PubMed     Text format     Abstract available


  6. NEUNER JM, Fergestrom NM, Laud PW, Nattinger AB, et al
    The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.
    Cancer. 2019 Aug 2. doi: 10.1002/cncr.32433.
    PubMed     Text format     Abstract available


  7. MANZ CR
    Getting in sync with adherence to endocrine therapy in breast cancer.
    Cancer. 2019 Aug 2. doi: 10.1002/cncr.32434.
    PubMed     Text format    


  8. PRINTZ C
    First person profile: Larry Norton, MD: A world-renowned breast cancer researcher, Dr. Norton has used his passion for music and math to revolutionize oncology.
    Cancer. 2019;125:2525-2527.
    PubMed     Text format    


    July 2019
  9. PEREZ EA, Barrios C, Eiermann W, Toi M, et al
    Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
    Cancer. 2019 Jul 18. doi: 10.1002/cncr.32392.
    PubMed     Text format     Abstract available


  10. DUSTIN D, Gu G, Fuqua SAW
    ESR1 mutations in breast cancer.
    Cancer. 2019 Jul 18. doi: 10.1002/cncr.32345.
    PubMed     Text format     Abstract available


  11. PRINTZ C
    Study: Patients with HER2-positive, stage IV breast cancer experienced better survival with surgery.
    Cancer. 2019;125:2337.
    PubMed     Text format    


  12. SCOTT LC, Mobley LR, Kuo TM, Il'yasova D, et al
    Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
    Cancer. 2019 Jul 8. doi: 10.1002/cncr.32207.
    PubMed     Text format     Abstract available


    June 2019
  13. MORI M, Fujimori M, van Vliet LM, Yamaguchi T, et al
    Explicit prognostic disclosure to Asian women with breast cancer: A randomized, scripted video-vignette study (J-SUPPORT1601).
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32327.
    PubMed     Text format     Abstract available


  14. LILLEBORGE M, Falk RS, Russnes H, Sauer T, et al
    Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32330.
    PubMed     Text format     Abstract available


  15. WEITZEL JN, Neuhausen SL, Adamson A, Tao S, et al
    Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32083.
    PubMed     Text format     Abstract available


  16. WALSH SM, Zabor EC, Stempel M, Morrow M, et al
    Does race predict survival for women with invasive breast cancer?
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32296.
    PubMed     Text format     Abstract available


  17. NAROD SA
    Genetic testing for breast cancer in the Hispanic community.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32334.
    PubMed     Text format    


  18. MEISEL JL, O'Regan RM
    Race, breast cancer, and prognosis: Where biology is queen?
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32294.
    PubMed     Text format    


  19. SUNG H, DeSantis CE, Fedewa SA, Kantelhardt EJ, et al
    Breast cancer subtypes among Eastern-African-born black women and other black women in the United States.
    Cancer. 2019 Jun 13. doi: 10.1002/cncr.32293.
    PubMed     Text format     Abstract available


    May 2019
  20. FAYANJU OM, Yenokyan K, Ren Y, Goldstein BA, et al
    The effect of treatment on patient-reported distress after breast cancer diagnosis.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32174.
    PubMed     Text format     Abstract available


  21. WASSERMANN J, Gelber SI, Rosenberg SM, Ruddy KJ, et al
    Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32192.
    PubMed     Text format     Abstract available


  22. HENRY NL, Cannon-Albright LA
    Breast cancer histologic subtypes show excess familial clustering.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32198.
    PubMed     Text format     Abstract available


  23. LIU Y, West R, Weber JD, Colditz GA, et al
    Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32200.
    PubMed     Text format     Abstract available


  24. NYROP KA, Deal AM, Reeder-Hayes KE, Shachar SS, et al
    Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
    Cancer. 2019 May 15. doi: 10.1002/cncr.32175.
    PubMed     Text format     Abstract available


  25. DEMISSEI BG, Finkelman BS, Hubbard RA, Zhang L, et al
    Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy.
    Cancer. 2019 May 1. doi: 10.1002/cncr.32149.
    PubMed     Text format     Abstract available


    April 2019
  26. LYNCH BM, Nguyen NH, Moore MM, Reeves MM, et al
    A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32143.
    PubMed     Text format     Abstract available


  27. HAWKINS BRESSLER L, Mersereau JE, Anderson C, Rodriguez JL, et al
    Fertility-related experiences after breast cancer diagnosis in the Sister and Two Sister Studies.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32126.
    PubMed     Text format     Abstract available


  28. PRINTZ C
    Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer.
    Cancer. 2019;125:1213.
    PubMed     Text format    



  29. "Development and validation of algorithms to differentiate ductal carcinoma in situ from invasive breast cancer within administrative claims data" by Hirth JM, Hatch SS, Lin Y, Giordano SH, Silva HC, Kuo Y.
    Cancer. 2019;125:1200.
    PubMed     Text format     Abstract available


  30. PRINTZ C
    Circulating tumor cell count could be used to determine treatment of metastatic breast cancer.
    Cancer. 2019;125:1021.
    PubMed     Text format    


  31. RANA HQ, Sacca R, Drogan C, Gutierrez S, et al
    Prevalence of germline variants in inflammatory breast cancer.
    Cancer. 2019 Apr 1. doi: 10.1002/cncr.32062.
    PubMed     Text format     Abstract available


    March 2019
  32. YU KD, Wu SY, Liu GY, Wu J, et al
    Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.
    Cancer. 2019 Mar 20. doi: 10.1002/cncr.32057.
    PubMed     Text format     Abstract available


  33. PRINTZ C
    Study projects a 43% increase in lung cancer mortality among women: New research suggests that, among women, strides in reducing global deaths from breast cancer could be tempered by rising lung cancer deaths. However, according to experts, the projec
    Cancer. 2019;125:831-832.
    PubMed     Text format    


  34. BAGLIA ML, Lin IH, Cartmel B, Sanft T, et al
    Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32051.
    PubMed     Text format     Abstract available


  35. DEAN LT, Moss SL, Rollinson SI, Frasso Jaramillo L, et al
    Patient recommendations for reducing long-lasting economic burden after breast cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32012.
    PubMed     Text format     Abstract available


    February 2019
  36. AUMEERUDDY MZ, Mahomoodally MF
    Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone.
    Cancer. 2019 Feb 27. doi: 10.1002/cncr.32022.
    PubMed     Text format     Abstract available


  37. BALAZY KE, Benitez CM, Gutkin PM, Jacobson CE, et al
    Association between primary language, a lack of mammographic screening, and later stage breast cancer presentation.
    Cancer. 2019 Feb 15. doi: 10.1002/cncr.32027.
    PubMed     Text format     Abstract available


  38. GIANNAKEAS V, Narod SA
    The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.32008.
    PubMed     Text format    


  39. DUFFY SW, Smith RA, Tabar L, Dean PB, et al
    Reply to The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.32007.
    PubMed     Text format    


  40. HENDRICK RE, Baker JA, Helvie MA
    Breast cancer deaths averted over 3 decades.
    Cancer. 2019 Feb 11. doi: 10.1002/cncr.31954.
    PubMed     Text format     Abstract available


  41. PRINTZ C
    Black women less likely to adhere to hormone therapy for breast cancer.
    Cancer. 2019;125:331.
    PubMed     Text format    


  42. EUHUS DM, Addae JK, Snyder CF, Canner JK, et al
    Change in health-related quality of life in older women after diagnosis of a small breast cancer.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31993.
    PubMed     Text format     Abstract available


  43. WALLNER LP, Li Y, McLeod MC, Gargaro J, et al
    Primary care provider-reported involvement in breast cancer treatment decisions.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31998.
    PubMed     Text format     Abstract available


  44. PARTRIDGE AH, Ruddy KJ, Barry WT, Greaney ML, et al
    A randomized study to improve care for young women with breast cancer at community and academic medical oncology practices in the United States: The Young and Strong study.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31984.
    PubMed     Text format     Abstract available


    January 2019
  45. BEDROSIAN I, Parker PA, Brewster AM
    Who should get a contralateral prophylactic mastectomy for breast cancer?
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31915.
    PubMed     Text format    


  46. AMMITZBOLL G, Johansen C, Lanng C, Andersen EW, et al
    Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial.
    Cancer. 2019 Jan 11. doi: 10.1002/cncr.31962.
    PubMed     Text format     Abstract available


  47. TAUB CJ, Lippman ME, Hudson BI, Blomberg BB, et al
    The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment.
    Cancer. 2019 Jan 11. doi: 10.1002/cncr.31965.
    PubMed     Text format     Abstract available


  48. VEENSTRA CM, Wallner LP, Abrahamse PH, Janz NK, et al
    Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment.
    Cancer. 2019 Jan 11. doi: 10.1002/cncr.31956.
    PubMed     Text format     Abstract available


    December 2018
  49. CHIN AL, Bentley JP, Pollom EL
    The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer.
    Cancer. 2018 Dec 19. doi: 10.1002/cncr.31910.
    PubMed     Text format     Abstract available


  50. BOWER JE, Asher A, Garet D, Petersen L, et al
    Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31827.
    PubMed     Text format     Abstract available


  51. KOELMEYER LA, Borotkanics RJ, Alcorso J, Prah P, et al
    Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31873.
    PubMed     Text format     Abstract available


  52. SENEVIRATNE MG, Bozkurt S, Patel MI, Seto T, et al
    Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer.
    Cancer. 2018 Dec 4. doi: 10.1002/cncr.31895.
    PubMed     Text format     Abstract available


    November 2018
  53. DIELI-CONWRIGHT CM, Sweeney FC, Courneya KS, Tripathy D, et al
    Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise in survivors of breast cancer.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31879.
    PubMed     Text format     Abstract available


  54. VAN DYK K, Crespi CM, Bower JE, Castellon SA, et al
    The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment.
    Cancer. 2018 Nov 28. doi: 10.1002/cncr.31858.
    PubMed     Text format     Abstract available


  55. CARROLL JE, Van Dyk K, Bower JE, Scuric Z, et al
    Cognitive performance in survivors of breast cancer and markers of biological aging.
    Cancer. 2018 Nov 26. doi: 10.1002/cncr.31777.
    PubMed     Text format     Abstract available


  56. TABAR L, Dean PB, Chen TH, Yen AM, et al
    The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
    Cancer. 2018 Nov 8. doi: 10.1002/cncr.31840.
    PubMed     Text format     Abstract available


  57. KALINSKY K, O'Regan RM
    Lymph node involvement: Positive about the role of the recurrence score in estrogen-driven breast cancer?
    Cancer. 2018 Nov 2. doi: 10.1002/cncr.31814.
    PubMed     Text format    


  58. GREENWALD MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, et al
    Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.
    Cancer. 2018 Nov 2. doi: 10.1002/cncr.31798.
    PubMed     Text format     Abstract available


    October 2018
  59. CAUDLE AS, Kuerer HM, Krishnamurthy S, Shin K, et al
    Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31825.
    PubMed     Text format     Abstract available


  60. LAMBERTINI M, Martel S, Campbell C, Guillaume S, et al
    Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
    Cancer. 2018 Oct 18. doi: 10.1002/cncr.31784.
    PubMed     Text format     Abstract available


  61. LANDEIRO LCG, Gagliato DM, Fede AB, Fraile NM, et al
    Return to work after breast cancer diagnosis: An observational prospective study in brazil.
    Cancer. 2018 Oct 17. doi: 10.1002/cncr.31735.
    PubMed     Text format     Abstract available


  62. HOSKINS KF, Tejeda S, Vijayasiri G, Chukwudozie IB, et al
    A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Cancer. 2018 Oct 15. doi: 10.1002/cncr.31635.
    PubMed     Text format     Abstract available


  63. ROCQUE GB, Williams CP, Kenzik KM, Jackson BE, et al
    Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Cancer. 2018 Oct 14. doi: 10.1002/cncr.31694.
    PubMed     Text format     Abstract available


  64. ROMANOFF A, Zabor EC, Petruolo O, Stempel M, et al
    Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers?
    Cancer. 2018 Oct 11. doi: 10.1002/cncr.31757.
    PubMed     Text format     Abstract available


  65. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
    Weight loss and breast cancer incidence in postmenopausal women.
    Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
    PubMed     Text format     Abstract available


  66. ANDERSON C, Nichols HB, Deal AM, Mark Park YM, et al
    Changes in cardiovascular disease risk and risk factors among women with and without breast cancer.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31775.
    PubMed     Text format     Abstract available


  67. PERNAS S, Barroso-Sousa R, Tolaney SM
    Optimal treatment of early stage HER2-positive breast cancer.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31657.
    PubMed     Text format     Abstract available


  68. GORNICK MC, Kurian AW, An LC, Fagerlin A, et al
    Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial.
    Cancer. 2018 Oct 5. doi: 10.1002/cncr.31731.
    PubMed     Text format     Abstract available


    September 2018
  69. KEHL KL, Niu J, Chavez-MacGregor M, Giordano SH, et al
    Hospitalization by cytotoxic chemotherapy regimen among older women with stage IV breast cancer.
    Cancer. 2018 Sep 28. doi: 10.1002/cncr.31760.
    PubMed     Text format     Abstract available


  70. KIM SJ, Glassgow AE, Watson KS, Molina Y, et al
    Gendered and Racialized Social Expectations, Barriers, and Delayed Breast Cancer Diagnosis.
    Cancer. 2018 Sep 24. doi: 10.1002/cncr.31636.
    PubMed     Text format     Abstract available


  71. GUO F, Kuo YF, Shih YCT, Giordano SH, et al
    Trends in Breast Cancer Mortality by Stage at Diagnosis Among Young Women in the United States.
    Cancer. 2018 Sep 6. doi: 10.1002/cncr.31638.
    PubMed     Text format     Abstract available



  72. MINDACT study results show low risk of local recurrence after 5 years for patients with early breast cancer.
    Cancer. 2018;124:3466-3467.
    PubMed     Text format    



  73. First person: George Sledge, Jr, MD: Former ASCO president leads breast cancer research and mentors Stanford faculty.
    Cancer. 2018;124:3465.
    PubMed     Text format    


    August 2018

  74. Many Women With the Most Common Form of Breast Cancer Can Skip Chemotherapy: Study finds that approximately 70% of patients with this form of the disease do not need adjuvant chemotherapy.
    Cancer. 2018;124:3281-2382.
    PubMed     Text format    


    July 2018
  75. JAGSI R, Ward KC, Abrahamse PH, Wallner LP, et al
    Unmet Need for Clinician Engagement Regarding Financial Toxicity After Diagnosis of Breast Cancer.
    Cancer. 2018 Jul 23. doi: 10.1002/cncr.31532.
    PubMed     Text format     Abstract available


  76. DASH C, Taylor TR, Makambi KH, Hicks J, et al
    Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: The FIERCE study.
    Cancer. 2018 Jul 5. doi: 10.1002/cncr.31569.
    PubMed     Text format     Abstract available


  77. PRINTZ C
    Older women with a family history of breast cancer face increased risk of the disease.
    Cancer. 2018;124:2673.
    PubMed     Text format    


    June 2018
  78. BAIL JR, Fruge AD, Cases MG, De Los Santos JF, et al
    A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31559.
    PubMed     Text format     Abstract available


  79. FRANK RD, Winham SJ, Vierkant RA, Frost MH, et al
    Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31528.
    PubMed     Text format     Abstract available


    May 2018
  80. VALACHIS A, Mamounas EP, Mittendorf EA, Hayashi N, et al
    Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.
    Cancer. 2018 May 3. doi: 10.1002/cncr.31518.
    PubMed     Text format     Abstract available


    April 2018
  81. SHUMWAY DA, Griffith KA, Hawley ST, Wallner LP, et al
    Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31378.
    PubMed     Text format     Abstract available


  82. HIRTH JM, Hatch SS, Lin YL, Giordano SH, et al
    Development and validation of algorithms to differentiate ductal carcinoma in situ from invasive breast cancer within administrative claims data.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31393.
    PubMed     Text format     Abstract available


  83. TURK AA, Wisinski KB
    PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31307.
    PubMed     Text format     Abstract available


  84. SCOTT JM, Iyengar NM, Nilsen TS, Michalski M, et al
    Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31368.
    PubMed     Text format     Abstract available


  85. OLAGUNJU TO, Liu Y, Liang LJ, Stomber JM, et al
    Disparities in the survivorship experience among Latina survivors of breast cancer.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31342.
    PubMed     Text format     Abstract available


    March 2018
  86. UEMURA MI, French JT, Hess KR, Liu D, et al
    Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31336.
    PubMed     Text format     Abstract available


  87. SCHWARTZ KL, Simon MS, Bylsma LC, Ruterbusch JJ, et al
    Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Cancer. 2018 Mar 5. doi: 10.1002/cncr.31299.
    PubMed     Text format     Abstract available


  88. FREEDMAN RA, Keating NL, Lin NU, Winer EP, et al
    Breast cancer-specific survival by age: Worse outcomes for the oldest patients.
    Cancer. 2018 Mar 2. doi: 10.1002/cncr.31308.
    PubMed     Text format     Abstract available


    February 2018
  89. PRINTZ C
    Patients with breast cancer who are treated with chemotherapy risk long-term nerve damage.
    Cancer. 2018;124:663.
    PubMed     Text format    


  90. EKENGA CC, Perez M, Margenthaler JA, Jeffe DB, et al
    Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls.
    Cancer. 2018 Feb 13. doi: 10.1002/cncr.31270.
    PubMed     Text format     Abstract available


  91. KWA MJ, Adams S
    Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here.
    Cancer. 2018 Feb 9. doi: 10.1002/cncr.31272.
    PubMed     Text format     Abstract available


    January 2018
  92. LITVAK A, Batukbhai B, Russell SD, Tsai HL, et al
    Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
    Cancer. 2018 Jan 30. doi: 10.1002/cncr.31260.
    PubMed     Text format     Abstract available


  93. REEDER-HAYES KE, Wheeler SB, Baggett CD, Zhou X, et al
    Influence of provider factors and race on uptake of breast cancer gene expression profiling.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31222.
    PubMed     Text format     Abstract available


  94. PILEWSKIE M, Morrow M
    Margins in breast cancer: How much is enough?
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31221.
    PubMed     Text format     Abstract available


  95. SIMON MS, Beebe-Dimmer JL, Hastert TA, Manson JE, et al
    Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31230.
    PubMed     Text format     Abstract available


    December 2017
  96. BALTZELL KA, Shen HM, Krishnamurty S, Sison JD, et al
    Bovine leukemia virus linked to breast cancer but not coinfection with human papillomavirus: Case-control study of women in Texas.
    Cancer. 2017 Dec 20. doi: 10.1002/cncr.31169.
    PubMed     Text format     Abstract available


  97. NUTTER EL, Weiss JE, Marotti JD, Barth RJ Jr, et al
    Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.
    Cancer. 2017 Dec 20. doi: 10.1002/cncr.31202.
    PubMed     Text format     Abstract available


  98. ARUN BK, Gutierrez Barrera AM, Ueno NT
    Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31188.
    PubMed     Text format    


  99. ALTUNDAG K
    Diagnosis of patients with inflammatory breast cancer is a problematic issue.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31189.
    PubMed     Text format    


  100. MILLER JW, Smith JL, Ryerson AB, Tucker TC, et al
    Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5100-5118.
    PubMed     Text format     Abstract available


  101. ROSENSTOCK AS, Niu J, Giordano SH, Zhao H, et al
    Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
    Cancer. 2017 Dec 13. doi: 10.1002/cncr.31144.
    PubMed     Text format     Abstract available


  102. OHRI N, Haffty BG, Buchholz TA
    The role of postmastectomy radiotherapy in patients with stage II breast cancer.
    Cancer. 2017 Dec 12. doi: 10.1002/cncr.31130.
    PubMed     Text format    


  103. PRINTZ C
    Physicians discuss ramifications of studies pointing to breast cancer overdiagnosis: New research under way attempts to better define who should be screened and treated.
    Cancer. 2017;123:4525-4527.
    PubMed     Text format    


    November 2017
  104. MANNEVILLE F, Rotonda C, Conroy T, Bonnetain F, et al
    The impact of physical activity on fatigue and quality of life during and after adjuvant treatment for breast cancer.
    Cancer. 2017 Nov 8. doi: 10.1002/cncr.31108.
    PubMed     Text format     Abstract available


  105. OHRI N, Sittig MP, Tsai CJ, Hwang ES, et al
    Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31080.
    PubMed     Text format     Abstract available


  106. SENNERSTAM RB
    Reply to Imaging modalities for the detection of distant metastases in breast cancer patients diagnosed in the 1970s and 1990s: Does it make any sense?
    Cancer. 2017 Nov 6. doi: 10.1002/cncy.21924.
    PubMed     Text format    


  107. ALTUNDAG K
    Imaging modalities for the detection of distant metastases in breast cancer patients diagnosed in the 1970s and 1990s: Does it make any sense?
    Cancer. 2017 Nov 6. doi: 10.1002/cncy.21925.
    PubMed     Text format    


    October 2017
  108. WALLACE AS, Keene KS, Williams CP, Jackson BE, et al
    Radiation therapy utilization in Medicare beneficiaries with early-stage breast cancer.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.30989.
    PubMed     Text format     Abstract available


  109. GUTIERREZ BARRERA AM, Fouad TM, Song J, Webster R, et al
    BRCA mutations in women with inflammatory breast cancer.
    Cancer. 2017 Oct 17. doi: 10.1002/cncr.31069.
    PubMed     Text format     Abstract available


  110. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available


  111. DONALDSON AR, McCarthy C, Goraya S, Pederson HJ, et al
    Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy.
    Cancer. 2017 Oct 10. doi: 10.1002/cncr.31061.
    PubMed     Text format     Abstract available


  112. JAGSI R, Abrahamse PH, Lee KL, Wallner LP, et al
    Treatment decisions and employment of breast cancer patients: Results of a population-based survey.
    Cancer. 2017 Oct 9. doi: 10.1002/cncr.30959.
    PubMed     Text format     Abstract available


  113. ARLEO EK, Hendrick RE, Helvie MA, Sickles EA, et al
    Comparison of recommendations for screening mammography using CISNET models.
    Cancer. 2017;123:3673-3680.
    PubMed     Text format     Abstract available


    September 2017
  114. CHAOUL A, Milbury K, Spelman A, Basen-Engquist K, et al
    Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.
    Cancer. 2017 Sep 20. doi: 10.1002/cncr.30938.
    PubMed     Text format     Abstract available


  115. HARTMAN SJ, Nelson SH, Myers E, Natarajan L, et al
    Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study.
    Cancer. 2017 Sep 19. doi: 10.1002/cncr.30987.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: